镇痛强度大,依赖性小,滥用潜力低的镇痛剂盐酸丁丙诺啡开始在我国临床推广使用,为我国镇痛药增添了新品种。但可待因复方制剂系列产品的开发应用与国际上许多国家比较,有不少差距。在临床上广泛应用的可待因复方制剂只有氨酚待因片(以下称氨酚待因片Ⅰ号,简称PC-1,每片含磷酸可待因8.4 mg和扑热息痛500 mg),开发新的可待因制剂品种是十分必要的。汕头(鱼它)滨制药厂和北京益民制药厂经卫生部审定批准,在PC-1组方的基础上,联合研 Analgesic strength, low dependence, low abuse potential analgesic buprenorphine hydrochloride began to promote clinical use in our country, added a new variety of analgesics in our country. However, codeine compound preparations for the development and application of products with many countries in the world, there are many gaps. In the clinical widely used codeine compound preparations only paracetamol tablets (hereinafter referred to as paracetamol tablets I, referred to as PC-1, each containing codeine phosphate 8.4 mg and paracetamol 500 mg), the development of new Of the codeine preparation variety is very necessary. Shantou (fish it) Haibin Pharmaceutical Factory and Beijing Yimin Pharmaceutical Factory approved by the Ministry of Health approved, on the basis of PC-1 group, the joint research